(Q38496456)

3 September 2017

title

Treatment of hepatorenal syndrome: lessons from the MARS trial (English)

1 reference

3 September 2017

1 reference

Kevin D Mullen

1

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

3 September 2017

1 reference

3 September 2017

volume

35

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

492-493

1 reference

Liver support by extracorporeal blood purification: a clinical observation

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.0350492

Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.0350492

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.0350492

Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.0350492

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.0350492

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.0350492

New treatments for hepatorenal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.0350492

10.1053/JHEP.2002.0350492

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference